Languages supported
120+
Human agents, not machine translation
Impact
Data quality
Misunderstood items → unusable data
Root cause
Underreported
Rarely listed in deviation reports
Multilingual Support Model
Human agents · Protocol-trained · 120+ languages
When eCOA compliance problems are investigated, language barriers rarely appear in the root cause documentation. The deviation report says "patient missed assessment" or "incomplete diary entry." It does not say "patient did not understand the instruction" or "patient was unable to reach study support in their language."
But the connection is real and systematic. Patients who are not fluent in the language of study communications take longer to complete assessments, answer PRO items less precisely, are less likely to reach out when they have problems, and disengage earlier. Each of these effects is measurable — and each degrades data quality in ways that are difficult to identify until the study is in analysis.
The operational implication is straightforward: language support is not a patient experience nicety. It is a data quality investment.
See also: Concierge-as-a-Service™ · eCOA & ePRO
The data quality effects of language barriers are not concentrated in one place. They compound across the full study workflow.
Validated ePRO scales require patients to understand what each item is asking. Misunderstood items produce responses that reflect the patient's interpretation of the question, not their actual health state. This is systematic measurement error that cannot be corrected at analysis.
Patients who find assessments confusing due to language difficulty are more likely to abandon them mid-completion or avoid them entirely. The compliance data looks like patient non-engagement when the root cause is language-driven difficulty.
Technology issues that are easily resolved with clear communication become data gaps when patients cannot explain the problem or understand the solution. Patients who cannot get effective help with technical issues stop using devices.
Dietary restrictions, timing requirements, activity protocols, and other pre-assessment instructions affect data validity. Patients who do not understand these instructions in their language produce data with unknown confounders.
Patients who cannot communicate effectively with their study support team are less likely to report adverse events or protocol deviations — creating safety and data integrity risks beyond compliance.
Patients who consistently struggle to communicate with the study team disengage progressively. Language-driven disengagement often looks like general retention failure and is not correctly identified or addressed.
Instrument validation requires forward and backward translation, reconciliation, cognitive debriefing with native speakers in the target population, and finalization. The process is defined by regulatory bodies including FDA and EMA. Unvalidated or machine-translated instruments are generally not accepted in regulatory submissions.
Language planning should be part of protocol design, not a late operational addition. Site-level language needs should be mapped based on expected patient demographics, and language support staffing — or a multilingual concierge service — should be confirmed before enrollment opens.
Automated translation is appropriate for non-critical communications — appointment confirmations, study newsletters, reminder messages. It is not appropriate for compliance-critical interactions where misunderstanding creates protocol deviations or data quality issues. Patient support interactions require human fluency.
Delve's Concierge-as-a-Service™ provides human patient support in 120+ languages — protocol-trained agents who keep patients engaged and compliant regardless of the language they speak.
Talk About Multilingual Support